Benitec Biopharma (BNTC) EPS (Basic) (2019 - 2025)
Benitec Biopharma (BNTC) posted EPS (Basic) of -$0.26 for Q4 2025, down 19.26% sequentially from -$0.22 in Q3 2025, and up 40.49% YoY from -$0.18 in Q4 2024.
Analysis
Benitec Biopharma (BNTC) EPS (Basic) (2019 - 2025) Analysis & Trends
Benitec Biopharma has reported EPS (Basic) for 7 years, with the latest figure at -$0.26 in Q4 2025.
- Quarterly EPS (Basic) rose 40.49% year-over-year to -$0.26 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was -$0.96 (up 10.29% YoY) and the FY2025 annual result came in at -$1.05, up 80.99% from the prior year.
- EPS (Basic) fell to -$0.26 in Q4 2025 per BNTC's latest filing, from -$0.22 in the prior quarter.
- Over five years, EPS (Basic) peaked at -$0.22 in Q3 2025 and troughed at -$16.02 in Q2 2021.
- A 5-year average of -$5.32 and a median of -$3.3 in 2023 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2021 and 2023: EPS (Basic) soared 94.05% in 2021, then decreased 15.55% in 2023.
- Over 5 years, EPS (Basic) stood at -$10.38 in 2021, then surged by 62.33% to -$3.91 in 2022, then jumped by 32.5% to -$2.64 in 2023, then jumped by 83.6% to -$0.43 in 2024, then surged by 40.49% to -$0.26 in 2025.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.26, -$0.22, and -$0.24 for Q4 2025, Q3 2025, and Q2 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 7.70 |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | -1.96 |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | -3.06 |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 2.12 |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 1.23 |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | 0.18 |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | -0.06 |
| 10 | Benitec Biopharma | 588.88 Mn | 588.88 Mn | - | -0.26 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | -0.26 |
| Sep 30, 2025 | -0.22 |
| Jun 30, 2025 | -0.45 |
| Mar 31, 2025 | -0.24 |
| Dec 31, 2024 | -0.43 |
| Sep 30, 2024 | -0.48 |
| Jun 30, 2024 | -1.16 |
| Mar 31, 2024 | -1.64 |
| Dec 31, 2023 | -2.64 |
| Sep 30, 2023 | -3.05 |
| Jun 30, 2023 | -3.29 |
| Mar 31, 2023 | -2.64 |
| Dec 31, 2022 | -3.47 |
| Sep 30, 2022 | -7.19 |
| Jun 30, 2022 | -9.88 |
| Mar 31, 2022 | -7.22 |
| Dec 31, 2021 | -10.08 |
| Sep 30, 2021 | -10.03 |
| Jun 30, 2021 | -15.26 |
| Mar 31, 2021 | -13.59 |